The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1279-1284

  Lavezzi, A M ^a   Biondo, B ^a   Cazzullo, A ^a   Giordano, F ^a   Pallotti, F ^a   Turconi, P ^a   Matturri, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Bladder carcinoma; DNA; Karyotype; PCNA; Prognosis; Superficial transitional cell biomarkers

Indexed keywords

CYCLINE; DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CHROMOSOME 7; CLINICAL TRIAL; CYTOMETRY; DIPLOIDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TETRASOMY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TRISOMY;

AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 7; DNA, NEOPLASM; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; URINARY BLADDER NEOPLASMS;

EID: 0035019744     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bladder tumours. Treated natural history
2. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
3. An analysis of the performance of pathologists in grading bladder tumors
4. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma
5. Progression and survival in transitional cell bladder cancer: A comparison of established prognostic factors, S-phase fraction and DNA ploidy
6. Study of cellular DNA content by flow cytometry in primary bladder carcinomas
7. Cell cycling in bladder carcinoma determined by monoclonal antibody Ki-67
8. Prognostic factors in bladder carcinoma: Histological parameters and expression of a cell-cycle-related nuclear antigen (Ki-67)
9. Accumulation of nuclear p53 and tumor progression in bladder cancer
10. Proliferating cell nuclear antigen in human transitional cell carcinoma
11. Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder
12. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value
13. Cell proliferation of human bladder tumors determined by BrdUrd and Ki- 67 immunostaining
14. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology
15. Kinetic pattern of human urinary transitional cell carcinoma
16. Chromosomal and cell kinetic pattern in human transitional cell bladder carcinoma
17. Recurrent chromosome alterations in transitional cell bladder carcinomas
18. Urothelial tumors of the urinary tract
19. Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of S-phase
20. Cyclin/PCNA is the auxiliary protein of DNA polymerase alpha
21. The application of immunohistochemistry in assessment of cellular proliferation
22. PCNA immunostaining as a valid alternative to tritiated thymidine-autoradiography to detect proliferative cell fraction in transitional cell bladder carcinomas
23. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression
24. Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: Differences between keratinizing and nonkeratinizing types
25. Apoptosis and proliferation in gastric carcinoma: The association with histological type
26. Correlation of apoptosis with tumour cell differentiation, progression and HPV infection in cervical carcinoma